.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
UBS
Teva
Covington
Healthtrust
Harvard Business School
QuintilesIMS
Julphar
Colorcon
Dow

Generated: September 20, 2017

DrugPatentWatch Database Preview

Travoprost - Generic Drug Details

« Back to Dashboard

What are the generic sources for travoprost and what is the scope of travoprost freedom to operate?

Travoprost
is the generic ingredient in four branded drugs marketed by Novartis Pharms Corp, Apotex Inc, Par Pharm, Mylan Pharms Inc, and Alcon Pharms Ltd, and is included in six NDAs. There are seven patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Travoprost has sixty-eight patent family members in twenty-four countries.

There are fourteen drug master file entries for travoprost. Three suppliers are listed for this compound. There are two tentative approvals for this compound.

Summary for Generic Name: travoprost

Tradenames:4
Patents:7
Applicants:5
NDAs:6
Drug Master File Entries: see list14
Suppliers / Packagers: see list3
Bulk Api Vendors: see list37
Clinical Trials: see list92
Patent Applications: see list2,164
Therapeutic Class:Ophthalmic Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:travoprost at DailyMed

Pharmacology for Ingredient: travoprost

Ingredient-typeProstaglandins
Drug ClassProstaglandin Analog

Tentative approvals for TRAVOPROST

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe0.004%SOLUTION; OPHTHALMIC
► Subscribe► Subscribe0.004%SOLUTION;OPHTHALMIC
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 2006ATRXYesYes► Subscribe► SubscribeY ► Subscribe
Alcon Pharms Ltd
TRAVATAN
travoprost
SOLUTION/DROPS;OPHTHALMIC021257-001Mar 16, 2001DISCNYesNo► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 2006ATRXYesYes► Subscribe► SubscribeY ► Subscribe
Novartis Pharms Corp
IZBA
travoprost
SOLUTION/DROPS;OPHTHALMIC204822-001May 15, 2014DISCNYesNo► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
IZBA
travoprost
SOLUTION/DROPS;OPHTHALMIC204822-001May 15, 2014DISCNYesNo► Subscribe► SubscribeY ► Subscribe
Novartis Pharms Corp
IZBA
travoprost
SOLUTION/DROPS;OPHTHALMIC204822-001May 15, 2014DISCNYesNo► Subscribe► SubscribeY ► Subscribe
Novartis Pharms Corp
IZBA
travoprost
SOLUTION/DROPS;OPHTHALMIC204822-001May 15, 2014DISCNYesNo► Subscribe► SubscribeY ► Subscribe
Apotex Inc
TRAVOPROST
travoprost
SOLUTION/DROPS;OPHTHALMIC203431-001Jul 10, 2015ATRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
TRAVOPROST
travoprost
SOLUTION/DROPS;OPHTHALMIC091340-001Mar 1, 2013RXNoYes► Subscribe► Subscribe► Subscribe
Novartis Pharms Corp
IZBA
travoprost
SOLUTION/DROPS;OPHTHALMIC204822-001May 15, 2014DISCNYesNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: travoprost

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alcon Pharms Ltd
TRAVATAN
travoprost
SOLUTION/DROPS;OPHTHALMIC021257-001Mar 16, 2001► Subscribe► Subscribe
Alcon Pharms Ltd
TRAVATAN
travoprost
SOLUTION/DROPS;OPHTHALMIC021257-001Mar 16, 2001► Subscribe► Subscribe
Alcon Pharms Ltd
TRAVATAN
travoprost
SOLUTION/DROPS;OPHTHALMIC021257-001Mar 16, 2001► Subscribe► Subscribe
Alcon Pharms Ltd
TRAVATAN
travoprost
SOLUTION/DROPS;OPHTHALMIC021257-001Mar 16, 2001► Subscribe► Subscribe
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 2006► Subscribe► Subscribe
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 2006► Subscribe► Subscribe
Alcon Pharms Ltd
TRAVATAN
travoprost
SOLUTION/DROPS;OPHTHALMIC021257-001Mar 16, 2001► Subscribe► Subscribe
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 2006► Subscribe► Subscribe
Novartis Pharms Corp
TRAVATAN Z
travoprost
SOLUTION/DROPS;OPHTHALMIC021994-001Sep 21, 2006► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: travoprost

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2008042619► Subscribe
South Africa200901702► Subscribe
European Patent Office2705836► Subscribe
Germany202009019114► Subscribe
Cyprus1112138► Subscribe
Slovenia2068822► Subscribe
TaiwanI544927► Subscribe
TaiwanI394564► Subscribe
Canada2606370► Subscribe
Mexico2009002221► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: TRAVOPROST

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0045France► SubscribePRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EU/1/01/199/001 20011127
00540Netherlands► SubscribePRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EU/1/01/199/001-002 20011127
1920764/01Switzerland► SubscribePRODUCT NAME: TRAVOPROST; REGISTRATION NUMBER/DATE: SWISSMEDIC 55910 22.05.2002
2014029Lithuania► SubscribePRODUCT NAME: TRAVOPROSTUM; REGISTRATION NO/DATE: EU/1/01/199/001 - EU/1/01/199/002 20011129
2012017Lithuania► SubscribePRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127
2014 00038Denmark► SubscribePRODUCT NAME: TRAVOPROST; REG. NO/DATE: EU/1/01/199/001-002 20011127
90027-0Sweden► SubscribePRODUCT NAME: TRAVOPROST
C/GB12/038United Kingdom► SubscribePRODUCT NAME: TRAVOPROST; REGISTERED: UK EU/1/01/199/001-002 20011129
00671Netherlands► SubscribePRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EG EU/1/01/199/001-002 20011128
2012017,C1920764Lithuania► SubscribePRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Baxter
Queensland Health
UBS
Chubb
Merck
US Department of Justice
US Army
Medtronic
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot